During the past decade, Liver Institute Northwest conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 1 clinical trials were completed, i.e. on average, 4.8% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 1 clinical trials were completed. i.e. 5.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Liver Institute Northwest" #1 sponsor was "Gilead Sciences" with 3 trials, followed by "Madrigal Pharmaceuticals, Inc." with 3 trials sponsored, "CymaBay Therapeutics, Inc." with 2 trials sponsored, "Boston Pharmaceuticals" with 1 trials sponsored and "Enanta Pharmaceuticals, Inc" with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Liver Institute Northwest" #1 collaborator was "Case Western Reserve University" with 2 trials as a collaborator, "Duke University" with 2 trials as a collaborator, "Indiana University" with 2 trials as a collaborator, "Liver Institute Northwest" with 2 trials as a collaborator and "St. Louis University" with 2 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Liver Institute Northwest" are "Primary Sclerosing Cholangitis" (4 trials), "Nonalcoholic Steatohepatitis" (3 trials), "Primary Biliary Cirrhosis" (3 trials), "NASH - Nonalcoholic Steatohepatitis" (2 trials) and "Non-Alcoholic Fatty Liver Disease" (2 trials). Many other conditions were trialed in "Liver Institute Northwest" in a lesser frequency.

Most popular intervention types in "Liver Institute Northwest" are "Drug" (20 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Resmetirom" (2 trials), "BOS-580" (1 trials), "CILO" (1 trials) and "Cenicriviroc" (1 trials). Other intervention names were less common.

The vast majority of trials in "Liver Institute Northwest" are 21 trials for "All" genders.

Currently, there are NaN active trials in "Liver Institute Northwest". undefined are not yet recruiting, 10 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Liver Institute Northwest, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Liver Institute Northwest, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".